Use of droloxifene for the treatment of protastic disease, endometriosis and obesity
AssigneePfizer Inc.
InventorDavid D. Thompson
Life of this patent
Estimating the term…
Abstract
This invention provides a method for treating a condition or disease selected from endometriosis, obesity, benign prostatic hypertrophy and prostatic carcinoma in mammals which comprises administering to said mammal an amount of droloxifene or a pharmaceutically acceptable salt thereof which is effective in treating said condition or disease.
Claims2
A method of treating (a disease or condition selected from endometriosis,) prostatic carcinoma (and obesity) in mammals which comprises administering to a mammal in need of such treatment an amount of droloxifene or a pharmaceutically acceptable salt thereof which is effective in treating said (disease or condition) prostatic carcinoma.
Dependencies are inferred from the claim text.